Skip to main content

Advertisement

SpringerLink
Log in

Immunologically mediated dementias

  • Published:
Current Neurology and Neuroscience Reports Aims and scope Submit manuscript

Abstract

Although most dementias are due to neurodegenerative or vascular disease, it is important to diagnose immunologically mediated dementias quickly because they can be both rapidly progressive and readily treatable. They usually affect function of limbic and cortical structures, but subcortical involvement can also occur. Because of the variety of symptoms and the rapid course, these dementias present a particular challenge to the clinician and may require evaluation and intervention in the inpatient setting. Diagnostic workup typically reveals evidence of an autoimmune process and, in some cases, cancer. In contrast to the neurodegenerative processes, many of the immunologically mediated dementias respond to immunomodulatory therapy.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References and Recommended Reading

  1. Vernino S, Geschwind MD, Boeve B: Autoimmune encephalopathies. The Neurologist 2007, 13:140–147.

    Article  PubMed  Google Scholar 

  2. Pittock SJ, Kryzer TJ, Lennon VA: Paraneoplastic antibodies coexist and predict cancer, not neurological syndrome. Ann Neurol 2004, 56:715–719.

    Article  PubMed  CAS  Google Scholar 

  3. Dalmau J, Rosenfeld MR: Paraneoplastic syndromes of the CNS. Lancet Neurol 2008, 7:327–340.

    Article  PubMed  Google Scholar 

  4. Bataller L, Kleopa KA, Wu GF, et al.: Autoimmune limbic encephalitis in 39 patients: immunophenotypes and outcomes. J Neurol Neurosurg Psychiatry 2007, 78:381–385.

    Article  PubMed  CAS  Google Scholar 

  5. Samarasekera SR, Vincent A, Welch JL, et al.: Course and outcome of acute limbic encephalitis with negative voltage-gated potassium channel antibodies. J Neurol Neurosurg Psychiatry 2007, 78:391–394.

    Article  PubMed  CAS  Google Scholar 

  6. Vincent A, Buckley C, Schott JM, et al.: Potassium channel antibody-associated encephalopathy: a potentially immunotherapy-responsive form of limbic encephalitis. Brain 2004, 127(Pt 3):701–712.

    PubMed  Google Scholar 

  7. Geschwind MD, Tan KM, Lennon VA, et al.: Voltage-gated potassium channel autoimmunity mimicking Creutzfeldt-Jakob disease. Arch Neurol 2008, 65:1341–1346.

    Article  PubMed  Google Scholar 

  8. Tan KM, Lennon VA, Klein CJ, et al.: Clinical spectrum of voltage-gated potassium channel autoimmunity. Neurology 2008, 70:1883–1890.

    Article  PubMed  CAS  Google Scholar 

  9. Graus F, Dalmau J: Paraneoplastic neurological syndromes: diagnosis and treatment. Curr Opin Neurol 2007, 20:732–737.

    PubMed  Google Scholar 

  10. Bataller L, Wade DF, Graus F, et al.: Antibodies to Zic4 in paraneoplastic neurologic disorders and small-cell lung cancer. Neurology 2004, 62:778–782.

    PubMed  CAS  Google Scholar 

  11. Muehlschlegel S, Okun MS, Foote KD, et al.: Paraneoplastic chorea with leukoencephalopathy presenting with obsessive-compulsive and behavioral disorder. Mov Disord 2005, 20:1523–1527.

    Article  PubMed  Google Scholar 

  12. Dalmau J, Graus F, Villarejo V, et al.: Clinical analysis of anti-Ma2-associated encephalitis. Brain 2004, 127(Pt 8):1831–1844.

    Article  PubMed  Google Scholar 

  13. Castle J, Sakonju A, Dalmau J, Newman-Toker DE: Anti-Ma2-associated encephalitis with normal FDG-PET: a case of pseudo-Whipple’s disease. Nat Clin Pract Neurol 2006, 2:566–572; quiz 573.

    Article  PubMed  Google Scholar 

  14. Dalmau J, Gleichman AJ, Hughes EG, et al.: Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies. Lancet Neurol 2008, 7:1091–1098.

    Article  PubMed  CAS  Google Scholar 

  15. Lai M, Hughes EG, Peng X, et al.: AMPA receptor antibodies in limbic encephalitis alter synaptic receptor location. Ann Neurol 2009, 65:424–434.

    Article  PubMed  CAS  Google Scholar 

  16. Pittock SJ, Lucchinetti CF, Lennon VA: Anti-neuronal nuclear autoantibody type 2: paraneoplastic accompaniments. Ann Neurol 2003, 53:580–587.

    Article  PubMed  CAS  Google Scholar 

  17. Schott JM: Another case of voltage-gated potassium channel antibody-related encephalopathy? Eur Neurol 2006, 55:110.

    Article  PubMed  Google Scholar 

  18. McKeon A, Marnane M, O’Connell M, et al.: Potassium channel antibody associated encephalopathy presenting with a frontotemporal dementia like syndrome. Arch Neurol 2007, 64:1528–1530.

    Article  PubMed  Google Scholar 

  19. Tuzun E, Dalmau J: Limbic encephalitis and variants: classification, diagnosis and treatment. Neurologist 2007, 13:261–271.

    Article  PubMed  Google Scholar 

  20. Fatourechi V: Hashimoto’s encephalopathy: myth or reality? An endocrinologist’s perspective. Best Pract Res Clin Endocrinol Metab 2005, 19:53–66.

    Article  PubMed  CAS  Google Scholar 

  21. Chong JY, Rowland LP: What’s in a NAIM? Hashimoto encephalopathy, steroid-responsive encephalopathy associated with autoimmune thyroiditis, or nonvasculitic autoimmune meningoencephalitis? Arch Neurol 2006, 63:175–176.

    Article  PubMed  Google Scholar 

  22. Chong JY, Rowland LP, Utiger RD: Hashimoto encephalopathy: syndrome or myth? Arch Neurol 2003, 60:164–71.

    Article  PubMed  Google Scholar 

  23. Castillo P, Woodruff B, Caselli R, et al.: Steroid-responsive encephalopathy associated with autoimmune thyroiditis. Arch Neurol 2006, 63:197–202.

    Article  PubMed  Google Scholar 

  24. Kothbauer-Margreiter I, Sturzenegger M, Komor J, et al.: Encephalopathy associated with Hashimoto thyroiditis: diagnosis and treatment. J Neurol 1996, 243:585–593.

    Article  PubMed  CAS  Google Scholar 

  25. Chaudhuri A, Behan PO: The clinical spectrum, diagnosis, pathogenesis and treatment of Hashimoto’s encephalopathy (recurrent acute disseminated encephalomyelitis). Curr Med Chem 2003, 10:1945–1953.

    Article  PubMed  CAS  Google Scholar 

  26. Hollowell JG, Staehling NW, Flanders WD, et al.: Serum TSH, T(4), and thyroid antibodies in the United States population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III). J Clin Endocrinol Metab 2002, 87:489–499.

    Article  PubMed  CAS  Google Scholar 

  27. Poser S, Mollenhauer B, Kraubeta A, et al.: How to improve the clinical diagnosis of Creutzfeldt-Jakob disease. Brain 1999, 122(Pt 12):2345–2351.

    Article  PubMed  Google Scholar 

  28. Chang CC, Eggers SD, Johnson JK, et al.: Anti-GAD antibody cerebellar ataxia mimicking Creutzfeldt-Jakob disease. Clin Neurol Neurosurg 2007, 109:54–57.

    Article  PubMed  Google Scholar 

  29. Espay AJ, Chen R: Rigidity and spasms from autoimmune encephalomyelopathies: stiff-person syndrome. Muscle Nerve 2006, 34:677–690.

    Article  PubMed  CAS  Google Scholar 

  30. Barker RA, Revesz T, Thom M, et al.: Review of 23 patients affected by the stiff man syndrome: clinical subdivision into stiff trunk (man) syndrome, stiff limb syndrome, and progressive encephalomyelitis with rigidity. J Neurol Neurosurg Psychiatry 1998, 65:633–640.

    Article  PubMed  CAS  Google Scholar 

  31. Bushara KO: Neurologic presentation of celiac disease. Gastroenterology 2005, 128(4 Suppl 1):S92–S97.

    Article  PubMed  Google Scholar 

  32. Hu WT, Murray JA, Greenaway MC, et al.: Cognitive impairment and celiac disease. Arch Neurol 2006, 63:1440–1446.

    Article  PubMed  Google Scholar 

  33. Hadjivassiliou M, Grunewald RA, Davies-Jones GA: Gluten sensitivity as a neurological illness. J Neurol Neurosurg Psychiatry 2002, 72:560–563.

    Article  PubMed  CAS  Google Scholar 

  34. Ventura A, Neri E, Ughi C, et al.: Gluten-dependent diabetes-related and thyroid-related autoantibodies in patients with celiac disease. J Pediatr 2000, 137:263–265.

    Article  PubMed  CAS  Google Scholar 

  35. Alaedini A, Green PH: Narrative review: celiac disease: understanding a complex autoimmune disorder. Ann Intern Med 2005, 142:289–298.

    PubMed  CAS  Google Scholar 

  36. Green PH, Cellier C: Celiac disease. N Engl J Med 2007, 357:1731–1743.

    Article  PubMed  CAS  Google Scholar 

  37. Boscolo S, Sarich A, Lorenzon A, et al.: Gluten ataxia: passive transfer in a mouse model. Ann N Y Acad Sci 2007, 1107:319–328.

    Article  PubMed  CAS  Google Scholar 

  38. Alaedini A, Okamoto H, Briani C, et al.: Immune crossreactivity in celiac disease: anti-gliadin antibodies bind to neuronal synapsin I. J Immunol 2007, 178:6590–6595.

    PubMed  CAS  Google Scholar 

  39. Hadjivassiliou M, Sanders DS, Woodroofe N, et al.: Gluten ataxia. Cerebellum 2008, 7:494–498.

    Article  PubMed  CAS  Google Scholar 

  40. Hadjivassiliou M, Grunewald R, Sharrack B, et al.: Gluten ataxia in perspective: epidemiology, genetic susceptibility and clinical characteristics. Brain 2003, 126(Pt 3):685–691.

    Article  PubMed  Google Scholar 

  41. Rosenbaum RB, Campbell SM, Rosenbaum JT: Clinical Neurology of Rheumatic Diseases. Boston: Butterworth-Heinemann; 1996.

    Google Scholar 

  42. Chin RL, Latov N: Central nervous system manifestations of rheumatologic diseases. Curr Opin Rheumatol 2005, 17:91–99.

    PubMed  Google Scholar 

  43. Josephs KA, Rubino FA, Dickson DW: Nonvasculitic autoimmune inflammatory meningoencephalitis. Neuropathology 2004, 24:149–152.

    Article  PubMed  Google Scholar 

  44. Delalande S, de Seze J, Fauchais AL, et al.: Neurologic manifestations in primary Sjogren syndrome: a study of 82 patients. Medicine (Baltimore) 2004, 83:280–291.

    Article  Google Scholar 

  45. Jennekens FG, Kater L: The central nervous system in systemic lupus erythematosus. Part 2. Pathogenetic mechanisms of clinical syndromes: a literature investigation. Rheumatology (Oxford) 2002, 41:619–630.

    Article  CAS  Google Scholar 

  46. Moritani T, Hiwatashi A, Shrier DA, et al.: CNS vasculitis and vasculopathy: efficacy and usefulness of diffusionweighted echoplanar MR imaging. Clin Imaging 2004, 28:261–270.

    Article  PubMed  Google Scholar 

  47. Levine SR, Brey RL, Tilley BC, et al.: Antiphospholipid antibodies and subsequent thrombo-occlusive events in patients with ischemic stroke. JAMA 2004, 291:576–584.

    Article  PubMed  CAS  Google Scholar 

  48. Lury KM, Smith JK, Matheus MG, Castillo M: Neurosarcoidosis3-review of imaging findings. Semin Roentgenol 2004, 39:495–504.

    Article  PubMed  Google Scholar 

  49. Younger DS, Hays AP, Brust JC, Rowland LP: Granulomatous angiitis of the brain. An inflammatory reaction of diverse etiology. Arch Neurol 1988, 45:514–518.

    PubMed  CAS  Google Scholar 

  50. Schielke E, Nolte C, Muller W, Bruck W: Sarcoidosis presenting as rapidly progressive dementia: clinical and neuropathological evaluation. J Neurol 2001, 248:522–524.

    Article  PubMed  CAS  Google Scholar 

  51. Behcet H: Über die rezidivierende aphtÖse durch ein virus verursachte geschwüre am auge und an den genitalien. Dermatol Wochenschr 1937, 105:1152–1157.

    Google Scholar 

  52. Akman-Demir G, Serdaroglu P, Tasci B: Clinical patterns of neurological involvement in Behcet’s disease: evaluation of 200 patients. The Neuro-Behcet Study Group. Brain 1999, 122(Pt 11):2171–2182.

    Article  PubMed  Google Scholar 

  53. Siva A, Kantarci OH, Saip S, et al.: Behcet’s disease: diagnostic and prognostic aspects of neurological involvement. J Neurol 2001, 248:95–103.

    Article  PubMed  CAS  Google Scholar 

  54. Oktem-Tanor O, Baykan-Kurt B, Gurvit IH, et al.: Neuropsychological follow-up of 12 patients with neuro-Behcet disease. J Neurol 1999, 246:113–119.

    Article  PubMed  CAS  Google Scholar 

  55. Yazici H, Yurdakul S, Hamuryudan V: Behcet disease. Curr Opin Rheumatol 2001, 13:18–22.

    Article  PubMed  CAS  Google Scholar 

  56. Berlit P: Primary angiitis of the CNS — an enigma that needs world-wide efforts to be solved. Eur J Neurol 2009, 16:10–11.

    Article  PubMed  CAS  Google Scholar 

  57. Iannuzzi MC, Rybicki BA, Teirstein AS: Sarcoidosis. N Engl J Med 2007, 357:2153–2165.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. UCSF Memory and Aging Center, Box 1207, San Francisco, CA, 94143, USA

    Michael H. Rosenbloom

Authors
  1. Michael H. Rosenbloom
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Sallie Smith
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Gulden Akdal
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Michael D. Geschwind
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Michael H. Rosenbloom.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Rosenbloom, M.H., Smith, S., Akdal, G. et al. Immunologically mediated dementias. Curr Neurol Neurosci Rep 9, 359–367 (2009). https://doi.org/10.1007/s11910-009-0053-2

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11910-009-0053-2

Keywords

Search

Navigation